Brevibacterium sanguinis
DSM 15678
Name:
Brevibacterium sanguinis Wauters et al. 2004
DSM No.:
15678 dsm-15678 dsm15678 dsm 15678 Brevibacterium sanguinis
Strain designation:
CF52
Other collection no.
or WDCM no.:
or WDCM no.:
CCUG 47858
Isolated from:
human blood
Country:
Belgium
Date of sampling:
before 16.06.2003
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- G. Wauters; CF52 <- J. Verhaegen
Cultivation conditions:
Summary and
additional information:
additional information:
<- G. Wauters; CF52 <- J. Verhaegen. Human blood; Belgium. Taxonomy/description (9308). (Medium 693 or 92, 37°C)
Literature:
Risk group:
2 (classification according to German TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
Supplied as:
Delivery form | Prices | ||
Freeze Dried | 100,- € | ||
Active culture on request | 240,- € | ||
DNA | 150,- € | ||
Price Category for this culture: 1 |
Freight and handling charges will be added. See price list.
Note: Freight charges for Risk Group 2 microorganisms will apply.
Other cultures: